in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Omkar Speciality Chemicals Enters API Business
7:20 AM MDT | April 17, 2012 | Deepti Ramesh
Omkar Speciality Chemicals (Thane, India) says it has entered the pharmaceutical ingredients business with the acquisition of LASA Laboratory (Raigad, India). LASA is an established player in the anthelmintic/veterinary active pharmaceutical ingredient (API) segment with an API manufacturing facility. Omkar Speciality Chemicals manufactures specialty chemicals, such as selenium derivatives, iodine derivatives, molybdenum derivatives, cobalt bismuth derivatives and pharma intermediates for life saving drugs. “There is a colossal demand in the API...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee